CML Newswire Archives is part of CMLHope.Com which has over 2,000 members in our online support group and operates free local monthly CML support meetings in 651 cities in over 60 counties.

Saturday, February 10, 2007

CML Newswire Archives Moved To New Site

All of the old blog archives of CMLNewswire have been moved to our new site at
http://cmlnewswire.wordpress.com

Wednesday, July 26, 2006

CML Newswire Moves To Wordpress

Because of frequent problems with the Blogger/Blogspot system future articles of CML Newswire will be posted at http://cmlnewswire.wordpress.com Old articles will still be archived at http://cmlsupport.blogspot.com


Saturday, June 03, 2006

Listing Of CML Clinical Trials

1.RecruitingDasatinib in Treating Patients With Accelerated Phase Chronic Myelogenous Leukemia, Blastic Phase Chronic Myelogenous Leukemia, or Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia
Conditions: Accelerated Phase Chronic Myelogenous Leukemia; Blastic Phase Chronic Myelogenous Leukemia; Recurrent Adult Acute Lymphoblastic Leukemia; ...2.RecruitingCladribine, Cytarabine, and Imatinib Mesylate in Treating Patients With Refractory or Relapsed Acute Myeloid Leukemia or Blastic Phase Chronic Myelogenous Leukemia
Conditions: Adult Acute Erythroid Leukemia; Adult Acute Monoblastic and Acute Monocytic Leukemia; Adult Acute Myeloid Leukemia; ...3.RecruitingFlavopiridol and Vorinostat in Treating Patients With Relapsed or Refractory Acute Leukemia or Chronic Myelogenous Leukemia or Refractory Anemia
Conditions: Adult Acute Lymphoblastic Leukemia; Adult Acute Myeloid Leukemia; Blastic Phase Chronic Myelogenous Leukemia; Myelodysplastic Syndromes; ...4.RecruitingCombination Chemotherapy and Thalidomide in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia, Chronic Myelogenous Leukemia, or Advanced Myelodysplastic Syndromes
Conditions: Adult Acute Myeloid Leukemia; Atypical Chronic Myeloid Leukemia; Childhood Acute Myeloid Leukemia and Other Myeloid Malignancies; ...5.RecruitingImatinib (GleevecĀ® (Registered Trademark)) to Treat Chronic Myelomonocytic Leukemia and Atypical Chronic Myelogenous Leukemia
Conditions: Chronic Myelomonocytic Leukemia; Chronic Myelogenous Leukemia6.RecruitingUCN-01 and Perifosine in Treating Patients With Relapsed or Refractory Acute Leukemia or Chronic Myelogenous Leukemia
Conditions: Adult Acute Erythroid Leukemia; Adult Acute Lymphoblastic Leukemia; Adult Acute Monoblastic and Acute Monocytic Leukemia; ...7.Not yet recruitingDasatinib in Treating Young Patients With Recurrent or Refractory Solid Tumors or Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia or Chronic Myelogenous Leukemia That Did Not Respond to Imatinib Mesylate
Conditions: Childhood Acute Lymphoblastic Leukemia; Childhood Solid Tumor; Chronic Myelogenous Leukemia8.RecruitingImatinib Mesylate and Decitabine in Treating Patients With Chronic Myelogenous Leukemia
Conditions: Accelerated Phase Chronic Myelogenous Leukemia; Blastic Phase Chronic Myelogenous Leukemia; ...9.RecruitingTemsirolimus and Imatinib Mesylate in Treating Patients With Chronic Myelogenous Leukemia
Conditions: Accelerated Phase Chronic Myelogenous Leukemia; Blastic Phase Chronic Myelogenous Leukemia; ...10.RecruitingSorafenib in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia, or Chronic Myelogenous Leukemia
Conditions: Adult Acute Erythroid Leukemia; Adult Acute Lymphoblastic Leukemia; Adult Acute Monoblastic and Acute Monocytic Leukemia; ...11.RecruitingFlavopiridol in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia, or Chronic Myelogenous Leukemia
Conditions: Adult Acute Erythroid Leukemia; Adult Acute Lymphoblastic Leukemia; Adult Acute Monoblastic and Acute Monocytic Leukemia; ...12.RecruitingImatinib Mesylate in Treating Patients With Chronic Myelogenous Leukemia
Conditions: Chronic Phase Chronic Myelogenous Leukemia; Philadelphia Chromosome Positive Chronic Myelogenous Leukemia; Childhood Chronic Myelogenous Leukemia13.RecruitingSJG-136 in Treating Patients With Relapsed or Refractory Acute Leukemia, Myelodysplastic Syndromes, or Blastic Phase Chronic Myelogenous Leukemia
Conditions: Adult Acute Lymphoblastic Leukemia; Adult Acute Myeloid Leukemia; Childhood Acute Myeloid Leukemia and Other Myeloid Malignancies; ...14.RecruitingRebeccamycin Analog in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia, Myelodysplastic Syndrome, Acute Lymphoblastic Leukemia, or Chronic Myelogenous Leukemia
Conditions: Adult Acute Lymphoblastic Leukemia; Adult Acute Myeloid Leukemia; Childhood Acute Myeloid Leukemia and Other Myeloid Malignancies; ...15.RecruitingSB-715992 in Treating Patients With Acute Leukemia, Chronic Myelogenous Leukemia, or Advanced Myelodysplastic Syndromes
Conditions: Acute Lymphocytic Leukemia; Acute Myeloid Leukemia; Acute Undifferentiated Leukemia; Adult Acute Erythroid Leukemia; ...16.Recruiting17-N-Allylamino-17-Demethoxygeldanamycin and Cytarabine in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia, Chronic Myelogenous Leukemia, Chronic Myelomonocytic Leukemia, or Myelodysplastic Syndromes
Conditions: Acute Lymphocytic Leukemia; Acute Myeloid Leukemia; Adult Acute Erythroid Leukemia; Adult Acute Monoblastic and Acute Monocytic Leukemia; ...17.RecruitingImatinib Mesylate in Treating Patients With Newly Diagnosed Chronic Phase Chronic Myelogenous Leukemia
Conditions: Philadelphia Chromosome Positive Chronic Myelogenous Leukemia; Chronic Phase Chronic Myelogenous Leukemia18.RecruitingSTI571 Plus Cytarabine in Treating Patients With Chronic Myelogenous Leukemia
Conditions: Relapsing Chronic Myelogenous Leukemia; Blastic Phase Chronic Myelogenous Leukemia; Philadelphia Chromosome Positive Chronic Myelogenous Leukemia19.RecruitingChemotherapy, Biological Therapy, and/or Bone Marrow or Peripheral Stem Cell Transplantation in Treating Patients With Chronic Myelogenous Leukemia
Conditions: Chronic Phase Chronic Myelogenous Leukemia; Philadelphia Chromosome Positive Chronic Myelogenous Leukemia; ...20.RecruitingCCI-779 in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia, Myelodysplastic Syndromes, or Chronic Myelogenous Leukemia in Blastic Phase
Conditions: Adult Acute Lymphoblastic Leukemia; Adult Acute Myeloid Leukemia; Childhood Acute Myeloid Leukemia and Other Myeloid Malignancies; ...21.RecruitingVaccine Therapy and Imatinib Mesylate in Treating Patients With Chronic Phase Chronic Myelogenous Leukemia
Conditions: Chronic Phase Chronic Myelogenous Leukemia; Philadelphia Chromosome Positive Chronic Myelogenous Leukemia22.RecruitingFludarabine and Total-Body Irradiation Followed By Cyclosporine and Mycophenolate Mofetil in Treating Patients Who Are Undergoing a Donor Stem Cell Transplant for Chronic Myelogenous Leukemia
Conditions: Accelerated Phase Chronic Myelogenous Leukemia; Philadelphia Chromosome Positive Chronic Myelogenous Leukemia; Relapsing Chronic Myelogenous Leukemia; ...23.RecruitingFludarabine and Radiation Therapy in Treating Patients Who Are Undergoing Donor Stem Cell Transplant for Chronic Phase or Accelerated Phase Chronic Myelogenous Leukemia
Conditions: Accelerated Phase Chronic Myelogenous Leukemia; Childhood Chronic Myelogenous Leukemia; Chronic Phase Chronic Myelogenous Leukemia; ...24.RecruitingImatinib Mesylate With or Without Interferon Alfa or Cytarabine Compared With Interferon Alfa Followed by Allogeneic Stem Cell Transplantation in Treating Patients With Newly Diagnosed Chronic Phase Chronic Myelogenous Leukemia
Conditions: Chronic Phase Chronic Myelogenous Leukemia; Childhood Chronic Myelogenous Leukemia25.RecruitingBMS-354825 in Treating Patients With Accelerated Phase Chronic Myelogenous Leukemia That Did Not Respond to Previous Imatinib Mesylate
Conditions: Accelerated Phase Chronic Myelogenous Leukemia; Philadelphia Chromosome Positive Chronic Myelogenous Leukemia; Relapsing Chronic Myelogenous Leukemia26.RecruitingBMS-354825 in Treating Patients With Blastic Phase Chronic Myelogenous Leukemia That Did Not Respond to Previous Imatinib Mesylate
Conditions: Blastic Phase Chronic Myelogenous Leukemia; Philadelphia Chromosome Positive Chronic Myelogenous Leukemia; Relapsing Chronic Myelogenous Leukemia27.RecruitingBMS-354825 in Treating Patients With Chronic Phase Chronic Myelogenous Leukemia That Did Not Respond to Previous Imatinib Mesylate
Conditions: Chronic Phase Chronic Myelogenous Leukemia; Philadelphia Chromosome Positive Chronic Myelogenous Leukemia; Relapsing Chronic Myelogenous Leukemia28.RecruitingBMS-354825 or Imatinib Mesylate in Treating Patients With Chronic Phase Chronic Myelogenous Leukemia That Did Not Respond to Previous Imatinib Mesylate
Conditions: Chronic Phase Chronic Myelogenous Leukemia; Philadelphia Chromosome Positive Chronic Myelogenous Leukemia; Relapsing Chronic Myelogenous Leukemia29.RecruitingBMS-354825 in Treating Patients With Chronic Phase Chronic Myelogenous Leukemia That Is Resistant to Imatinib Mesylate
Conditions: Chronic Phase Chronic Myelogenous Leukemia; Relapsing Chronic Myelogenous Leukemia; Philadelphia Chromosome Positive Chronic Myelogenous Leukemia30.Recruiting17-N-Allylamino-17-Demethoxygeldanamycin in Treating Patients With Chronic Phase Chronic Myelogenous Leukemia That Did Not Respond to Imatinib Mesylate
Conditions: Philadelphia Chromosome Positive Chronic Myelogenous Leukemia; Chronic Phase Chronic Myelogenous Leukemia; Relapsing Chronic Myelogenous Leukemia31.RecruitingBMS-354825 in Treating Patients With Blastic Phase Chronic Myelogenous Leukemia or Acute Lymphoblastic Leukemia That Did Not Respond to Previous Imatinib Mesylate
Conditions: Blastic Phase Chronic Myelogenous Leukemia; Philadelphia Chromosome Positive Chronic Myelogenous Leukemia; Relapsing Chronic Myelogenous Leukemia; ...32.RecruitingSorafenib in Treating Patients With Refractory or Relapsed Acute Leukemia, Myelodysplastic Syndromes, or Blastic Phase Chronic Myelogenous Leukemia
Conditions: Acute Lymphocytic Leukemia; Acute Myeloid Leukemia; Adult Acute Erythroid Leukemia; Adult Acute Monoblastic and Acute Monocytic Leukemia; ...33.RecruitingImatinib Mesylate in Treating Patients With Chronic Phase Chronic Myelogenous Leukemia
Conditions: Chronic Phase Chronic Myelogenous Leukemia; Philadelphia Chromosome Positive Chronic Myelogenous Leukemia34.RecruitingPhase II Trial of Decitabine in Patients With Chronic Myelogenous Leukemia Chronic Phase Who Are Refractory to Imatinib Mesylate (Gleevec)
Condition: Chronic Myelogenous Leukemia35.RecruitingPhase II Trial of Decitabine in Patients With Chronic Myelogenous Leukemia Accelerated Phase Who Are Refractory to Imatinib Mesylate (Gleevec)
Condition: Chronic Myelogenous Leukemia36.RecruitingPhase II Trial of Decitabine in Patients With Chronic Myelogenous Leukemia Blast Phase Who Are Refractory to Imatinib Mesylate (Gleevec)
Condition: Chronic Myelogenous Leukemia37.RecruitingVorinostat and Decitabine in Treating Patients With Advanced Solid Tumors or Relapsed or Refractory Non-Hodgkin's Lymphoma, Acute Myeloid Leukemia, Acute Lymphocytic Leukemia, or Chronic Myelogenous Leukemia
Conditions: Adult Acute Lymphoblastic Leukemia; Adult Acute Myeloid Leukemia; Adult Non-Hodgkin's Lymphoma; Adult Solid Tumor; Chronic Myelogenous Leukemia; ...38.RecruitingAG-858 and Imatinib Mesylate in Treating Patients With Chronic Phase Chronic Myelogenous Leukemia Who Were Previously Treated With Imatinib Mesylate
Conditions: Chronic Phase Chronic Myelogenous Leukemia; Philadelphia Chromosome Positive Chronic Myelogenous Leukemia39.RecruitingFludarabine and Total-Body Irradiation Followed By Donor Peripheral Stem Cell Transplantation in Treating Patients With Acute Lymphoblastic Leukemia or Chronic Myelogenous Leukemia That Has Responded to Treatment With Imatinib Mesylate
Conditions: Childhood Acute Lymphoblastic Leukemia in Remission; Childhood Acute Lymphoblastic Leukemia; Adult Acute Lymphoblastic Leukemia; ...40.RecruitingBiological Therapy in Treating Patients With Advanced Acute or Chronic Myeloid Leukemia or Acute Lymphoblastic Leukemia Who Are Undergoing Stem Cell Transplantation
Conditions: Adult Acute Lymphoblastic Leukemia; Adult Acute Myeloid Leukemia; Childhood Acute Lymphoblastic Leukemia; ...41.RecruitingClofarabine and Cyclophosphamide in Treating Patients With Relapsed or Refractory Acute Leukemia, Chronic Myelogenous Leukemia, or Myeloproliferative Disorders
Conditions: Adult Acute Erythroid Leukemia; Adult Acute Monoblastic and Acute Monocytic Leukemia; Childhood Acute Monocytic Leukemia; ...42.RecruitingCyclophosphamide and Filgrastim Followed By Peripheral Stem Cell Transplantation in Treating Patients With Chronic or Accelerated Phase Myelogenous Leukemia
Conditions: Chronic Phase Chronic Myelogenous Leukemia; Accelerated Phase Chronic Myelogenous Leukemia; ...43.RecruitingImatinib Mesylate and Cytarabine in Treating Patients With Newly Diagnosed Chronic Myeloid Leukemia
Conditions: Chronic Phase Chronic Myelogenous Leukemia; Philadelphia Chromosome Positive Chronic Myelogenous Leukemia44.RecruitingZarnestra and Gleevec in Chronic Phase Chronic Myelogenous Leukemia
Condition: Leukemia, Myeloid, Chronic45.RecruitingDonor Natural Killer Cell Infusion in Treating Patients Who Are Undergoing a Donor Stem Cell Transplant for Acute Myeloid Leukemia, Chronic Myeloid Leukemia, or Myelodysplastic Syndromes
Conditions: Adult Acute Myeloid Leukemia; Childhood Acute Myeloid Leukemia and Other Myeloid Malignancies; Chronic Myelogenous Leukemia; ...46.RecruitingPTK 787 and Gleevec in Patients With AML, AMM, and CML-BP
Conditions: Acute Myelogenous Leukemia; Agnogenic Myeloid Metaplasia; Chronic Myelogenous Leukemia47.RecruitingHigh-Dose Gleevec Alone or in Combination With Peg-Intron and GM-CSF in Early Phase Chronic Myelogenous Leukemia (CML)
Condition: Leukemia, Myeloid, Chronic48.RecruitingExpanded Access Program of AMN107 in Imatinib-Resistant or Intolerant Adult Patients With Chronic Myeloid Leukemia
Condition: Chronic Myeloid Leukemia49.RecruitingG-CSF in Stimulating Peripheral Stem Cells for Autologous Stem Cell Transplant in Treating Patients With Chronic Phase Chronic Myeloid Leukemia in Complete Remission
Condition: Chronic Phase Chronic Myelogenous Leukemia50.RecruitingTemozolomide and VNP40101M in Treating Patients With Relapsed or Refractory Leukemias
Conditions: Adult Acute Lymphoblastic Leukemia; Adult Acute Myeloid Leukemia; Blastic Phase Chronic Myelogenous Leukemia; Relapsing Chronic Myelogenous Leukemia; ...

51.RecruitingChemotherapy and Monoclonal Antibody Therapy in Treating Patients With Advanced Myeloid Cancer
Conditions: Adult Acute Myeloid Leukemia; Atypical Chronic Myeloid Leukemia; Childhood Acute Myeloid Leukemia and Other Myeloid Malignancies; ...52.RecruitingClofarabine Combinations in Relapsed/Refractory AML, MDS and Myeloid Blast Phase CML
Conditions: Acute Myeloid Leukemia; Myelodysplastic Syndrome; Chronic Myeloid Leukemia53.RecruitingSafety and Efficacy of Imatinib in Chronic Myelogenous Patients in Relapse After Stem Cell Transplantation
Condition: Chronic Myeloid Leukemia54.RecruitingAdoptive Immunotherapy and Interleukin-2 in Treating Patients With Recurrent Myeloid Leukemias After Undergoing Allogeneic Stem Cell Transplantation
Conditions: Adult Acute Myeloid Leukemia; Chronic Myelogenous Leukemia; Secondary Acute Myeloid Leukemia55.RecruitingImatinib Mesylate After a Donor Stem Cell Transplant in Treating Patients With Philadelphia Chromosome-Positive Leukemia
Conditions: Adult Acute Lymphoblastic Leukemia; Childhood Acute Lymphoblastic Leukemia; Chronic Myelogenous Leukemia56.RecruitingTotal-Body Irradiation, Thiotepa, and Fludarabine in Treating Young Patients Who Are Undergoing a Donor Stem Cell Transplant for Hematologic Cancer
Conditions: Childhood Acute Lymphoblastic Leukemia; Childhood Acute Myeloid Leukemia and Other Myeloid Malignancies; Chronic Myelogenous Leukemia; ...57.Not yet recruitingImatinib Mesylate and Zoledronic Acid in Patients With Chronic Myeloid Leukaemia in Cytogenetic Response Without Molecular Response
Condition: Myeloid Leukemia, Chronic58.RecruitingA Study of Oral AMN107 in Adults With Chronic Myelogenous Leukemia (CML) or Other Blood Related Cancers
Conditions: Chronic Myelogenous Leukemia; Acute Lymphoblastic Leukemia (Philadelphia Chromosome Positive); Hypereosinophilic Syndrome; Systemic Mastocytosis59.Not yet recruitingAllogeneic Tumor Cell Vaccination in Patients With Chronic Myeloid Leukemia
Condition: Chronic Myeloid Leukemia60.RecruitingDasatinib (BMS-354825) in Chronic Myelogenous Leukemia (CML)
Condition: Myelogenous Leukemia, Chronic61.RecruitingAlemtuzumab, Fludarabine, and Busulfan Followed By Donor Stem Cell Transplant in Treating Young Patients With Hematologic Disorders
Conditions: Diamond-Blackfan Anemia; Childhood Acute Myeloid Leukemia and Other Myeloid Malignancies; Chronic Myelogenous Leukemia; ...62.RecruitingDonor Stem Cell Transplant in Treating Young Patients With Myelodysplastic Syndrome, Leukemia, Bone Marrow Failure Syndrome, or Severe Immunodeficiency Disease
Conditions: Acute Lymphocytic Leukemia; Acute Myeloid Leukemia; Chronic Myelogenous Leukemia; Congenital Amegakaryocytic Thrombocytopenia; ...63.RecruitingVorinostat and Idarubicin in Treating Patients With Relapsed or Refractory Leukemia or Myelodysplastic Syndromes
Conditions: Adult Acute Lymphoblastic Leukemia; Adult Acute Myeloid Leukemia; Childhood Acute Myeloid Leukemia and Other Myeloid Malignancies; ...64.RecruitingA Study of Dasatinib in Patients With Chronic Myelogenous Leukemia (Accelerated Phase, Blast Phase or Ph+ ALL) Who Are Resistant or Intolerant of Imatinib Mesylate
Conditions: Chronic Myeloid Leukemia Accelerated and Blast Phase; Leukemia, Acute, Philadelphia-Positive65.RecruitingPhase 2 Trial of a CMV Vaccine in Donors and Recipients Undergoing Allogeneic Hematopoietic Cell Transplant (HCT)
Conditions: Acute Lymphoblastic Leukemia; Chronic Myelogenous Leukemia; Acute Myelogenous Leukemia; Hodgkins Lymphoma; Non-Hodgkin's Lymphoma; ...66.RecruitingUse of SV40 Vectors to Treat Chronic Myeloid Leukemia (CML)
Condition: Chronic Myeloid Leukemia67.RecruitingEfficacy of 400 Mg Versus 800 Mg Imatinib in Chronic Myeloid Leukemia in Chronic Phase Patients
Condition: Leukemia, Myeloid, Chronic Phase68.Not yet recruitingPhase I Study of Dasatinib (BMS-354825) and Imatinib in Subjects With Chronic Myeloid Leukemia in Chronic Phase
Condition: Chronic Phase Chronic Myelogenous Leukemia (CML)69.RecruitingStudy Comparing Standard Dose and High-Dose Imatinib Mesylate in Patients With Chronic Phase Ph+ CML
Condition: Chronic Phase Ph+ Chronic Myelogenous Leukemia70.RecruitingSTI571 ProspectIve RandomIzed Trial: SPIRIT
Condition: Chronic Myeloid Leukemia71.Not yet recruitingEfficacy and Safety of Oral AMN107 in Adults With Chronic Myelogenous Leukemia Resistant and/or Intolerant to Imatinib Mesylate Therapy
Condition: Chronic Mylogenous Leukemia (CML) Patients Resistant or Intolerant to Imatinib Mesylate Therapy72.RecruitingPilot Phase II - Synthetic Vaccine in CML
Condition: Chronic Myeloid Leukemia73.RecruitingGM-K562 Vaccination for CML Patients
Condition: Chronic Myeloid Leukemia74.RecruitingHomoharringtonine With Oral Gleevec in Chronic, Accelerated and Blast Phase Chronic Myeloid Leukemia (CML)
Conditions: Myeloid Leukemia, Chronic; Myeloid Leukemia, Chronic, Accelerated-Phase; Blast Phase; Myeloid Leukemia, Chronic, Chronic-Phase75.RecruitingBusulfan, Fludarabine, and Total-Body Irradiation in Treating Patients Who Are Undergoing a Donor Stem Cell Transplant for Hematologic Cancer
Conditions: Acute Leukemia; Atypical Chronic Myeloid Leukemia; Chronic Leukemia; Chronic Myeloproliferative Disorders; ...76.RecruitingComparing Imatinib Standard Dose With Imatinib High Dose Induction in Pretreated CML Patients in Chronic Phase
Condition: Chronic Myeloid Leukemia77.RecruitingAFR10 - Combination Therapy of Imatinib Mesylate (IM) + Alpha-2A Interferon for Chronic Phase CML Patients Resistant or Refractory to IM Used as Single Therapy for at Least One Year
Condition: Chronic Myeloid Leukemia78.RecruitingRadiolabeled Monoclonal Antibody Therapy Combined With Total-Body Irradiation, Allogeneic Peripheral Stem Cell Transplantation, and Immunosuppression Therapy in Treating Older Patients Who Have Advanced Acute Myeloid Leukemia, Myelodysplastic Syndrome, or Chronic Myelomonocytic Leukemia
Conditions: Adult Acute Myeloid Leukemia; Atypical Chronic Myeloid Leukemia; Chronic Myelomonocytic Leukemia; Graft Versus Host Disease; ...79.RecruitingVNP40101M in Treating Patients With Acute Myelogenous Leukemia or High-Risk Myelodysplasia
Conditions: Adult Acute Myeloid Leukemia; Atypical Chronic Myeloid Leukemia; Chronic Myelomonocytic Leukemia; Myelodysplastic and Myeloproliferative Disease; ...80.RecruitingIntensive Compared With Nonintensive Chemotherapy in Treating Older Patients With Acute Myeloid Leukemia or Myelodysplastic Syndrome
Conditions: Acute Myeloid Leukemia; Adult Acute Monoblastic and Acute Monocytic Leukemia; Atypical Chronic Myeloid Leukemia; Chronic Myelomonocytic Leukemia; ...81.RecruitingArsenic Trioxide, Ascorbic Acid, Dexamethasone, and Thalidomide in Treating Patients With Chronic Idiopathic Myelofibrosis or Myelodysplastic or Myeloproliferative Disorders
Conditions: Atypical Chronic Myeloid Leukemia; Chronic Idiopathic Myelofibrosis; Chronic Myelomonocytic Leukemia; Myelodysplastic and Myeloproliferative Disease; ...82.RecruitingDonor Stem Cell Transplantation With or Without Chemotherapy in Treating Children With Primary Myelodysplastic Syndrome
Conditions: Atypical Chronic Myeloid Leukemia; Chronic Myelomonocytic Leukemia; Juvenile Myelomonocytic Leukemia; Myelodysplastic and Myeloproliferative Disease; ...83.RecruitingLow-Dose Decitabine Compared With Standard Supportive Care in Treating Older Patients With Myelodysplastic Syndrome
Conditions: Atypical Chronic Myeloid Leukemia; Chronic Myelomonocytic Leukemia; Myelodysplastic and Myeloproliferative Disease; Myelodysplastic Syndromes84.RecruitingReduced-Intensity Regimen Before Donor Bone Marrow Transplantation in Treating Patients With Myelodysplastic Syndromes
Conditions: Atypical Chronic Myeloid Leukemia; Chronic Myelomonocytic Leukemia; Myelodysplastic and Myeloproliferative Disease; Myelodysplastic Syndromes85.RecruitingBone Marrow Transplantation in Treating Patients With Hematologic Cancers
Conditions: Acute Leukemia; Atypical Chronic Myeloid Leukemia; Chronic Leukemia; Chronic Myeloproliferative Disorders; ...86.RecruitingAlemtuzumab and Combination Chemotherapy Followed By Donor Lymphocytes in Treating Patients Who Are Undergoing Donor Stem Cell Transplant for Hematologic Cancer
Conditions: Acute Leukemia; Atypical Chronic Myeloid Leukemia; Chronic Leukemia; Chronic Myeloproliferative Disorders; ...87.RecruitingAlemtuzumab Plus Fludarabine and Melphalan With or Without Cyclosporine, Mycophenolate Mofetil, and Low-Dose Total-Body Irradiation Therapy Followed by Donor Peripheral Stem Cell Transplantation in Treating Patients With Hematologic Cancer
Conditions: Acute Leukemia; Atypical Chronic Myeloid Leukemia; Chronic Leukemia; Myelodysplastic and Myeloproliferative Disease; Non-Hodgkin's Lymphoma; ...88.RecruitingTherapy of Hypereosinophilic Syndrome, Polycythemia Vera, Atypical CML or CMML With PDGF-R Fusion Genes, or Mastocytosis With Gleevec
Conditions: Chronic Myelomonocytic Leukemia; Chronic Myeloid Leukemia; Polycythemia Vera; Hypereosinophilic Syndrome; Mastocytosis89.RecruitingUmbilical Cord Blood and Placental Blood Transplantation in Treating Patients With Hematologic Cancer or Aplastic Anemia
Conditions: Langerhans Cell Histiocytosis; Childhood Hodgkin's Lymphoma; Childhood Non-Hodgkin's Lymphoma; Hematopoietic and Lymphoid Cancer90.RecruitingStudy Evaluating the Safety and Efficacy of AMD3100 for Transplantation of Sibling Donor Stem Cells in Patients With Hematological Malignancies
Conditions: Acute Myelogenous Leukemia; Acute Lymphoblastic Leukemia; Myelodysplastic Syndrome; Chronic Myelogenous Leukemia; Non-Hodgkin Lymphoma; ...91.Not yet recruitingSafety and Efficacy of Unrelated Cord Blood Transplantation for Adult Patients With Hematologic Malignancies
Conditions: Acute Myelogenous Leukemia; Acute Lymphoblastic Leukemia; Chronic Myelogenous Leukemia; Myelodysplastic Syndrome92.RecruitingInfusion of Specially Treated Umbilical Cord Stem Cells After Chemoradiation Treatment for Blood Cancers
Conditions: Acute Lymphocytic Leukemia; Acute Myeloid Leukemia; Myelodysplastic Syndrome; Non-Hodgkin Lymphoma; Chronic Myelogenous Leukemia93.Not yet recruitingStudy of Dasatinib in Patients With Chronic Phase CML and a Suboptimal Response to Imatinib
Condition: Leukemia, Myeloid, Chronic94.RecruitingTotal-Body Irradiation Plus Chemotherapy Followed By Donor Bone Marrow Transplantation in Treating Children With Hematologic Cancer
Conditions: Acute Leukemia; Childhood Large Cell Lymphoma; Childhood Lymphoblastic Lymphoma; Childhood Small Noncleaved Cell Lymphoma; Chronic Leukemia; ...95.RecruitingEtanercept, Mycophenolate Mofetil, Denileukin Diftitox, or Pentostatin Combined With Prednisone or Methylprednisolone in Treating Patients With Acute Graft-Versus-Host Disease Who Have Undergone a Previous Donor Stem Cell Transplant
Conditions: Graft Versus Host Disease; Accelerated Phase Chronic Myelogenous Leukemia; ...96.RecruitingAllogeneic Transplantation for Patients With Acute Leukemia or CML
Conditions: Leukemia, Lymphocytic, Acute; Leukemia, Myeloid, Acute; Leukemia, Myeloid, Chronic97.RecruitingSelective T-Cell Depletion to Reduce Graft-Versus-Host-Disease in Patients Receiving Stem Cell Transplantation to Treat Leukemia, Lymphoma or Myelodysplastic Syndromes
Conditions: Graft vs Host Disease; Myelodysplastic Syndromes; Leukemia; Leukemia, Myeloid; Leukemia, Myelomonocytic, chronic; Leukemia, Lymphocytyc; Lymphoma; ...98.RecruitingTreatment Of Hematologic Malignancies With Single-Unit Or Double-Unit Cord Blood Transplantation
Conditions: Acute Myeloid Leukemia; Acute Lymphoblastic Leukemia; Chronic Myeloid Leukemia; Non-Hodgkin Lymphoma; Myelodysplastic Syndromes99.RecruitingVX-680, an Aurora Kinase Inhibitor, in Patients With Relapsed/Refractory Leukemia
Conditions: Myelogenous Leukemia, Acute; Lymphocytic Leukemia, B Cell, Acute; Myelodysplastic Syndromes; Myelogenous Leukemia, Chronic100.RecruitingArsenic Trioxide and Etanercept in Treating Patients With Myelodysplastic Syndromes
Conditions: De Novo Myelodysplastic Syndromes; Previously Treated Myelodysplastic Syndromes; Secondary Myelodysplastic Syndromes; ...

101.RecruitingAzacitidine and Etanercept in Treating Patients With Myelodysplastic Syndromes
Conditions: De Novo Myelodysplastic Syndromes; Previously Treated Myelodysplastic Syndromes; Secondary Myelodysplastic Syndromes; ...102.RecruitingDonor Peripheral Stem Cell Transplantation in Treating Patients With Myelodysplastic Syndrome, Acute Myeloid Leukemia, or Myeloproliferative Disorder
Conditions: Acute Leukemia; Atypical Chronic Myeloid Leukemia; Chronic Leukemia; Chronic Myeloproliferative Disorders; ...103.RecruitingMonoclonal Antibody Therapy in Treating Patients With Ovarian Epithelial Cancer, Melanoma, Acute Myeloid Leukemia, Myelodysplastic Syndrome, or Non-Small Cell Lung Cancer
Conditions: Acute Leukemia; Atypical Chronic Myeloid Leukemia; Melanoma; Myelodysplastic and Myeloproliferative Disease; Non-Small Cell Lung Cancer; ...104.RecruitingStudy Evaluating SKI-606 in Philadelphia Chromosome Positive Leukemias
Condition: Leukemia, Myeloid, Chronic105.RecruitingDecitabine and FR901228 in Treating Patients With Relapsed or Refractory Leukemia, Myelodysplastic Syndromes, or Myeloproliferative Disorders
Conditions: Adult Acute Erythroid Leukemia; Adult Acute Monoblastic and Acute Monocytic Leukemia; Chronic Myeloproliferative Disorders; Leukemia; ...106.RecruitingFilgrastim-Mobilized Peripheral Stem Cell Transplantation Compared With Bone Marrow Transplantation From Unrelated Donors in Treating Patients With Hematologic Malignancies
Conditions: Acute Leukemia; Chronic Leukemia; Chronic Myeloproliferative Disorders; Myelodysplastic and Myeloproliferative Disease107.RecruitingFilgrastim-Mobilized Peripheral Stem Cell Transplantation Compared With Bone Marrow Transplantation From Unrelated Donors in Treating Patients With Hematologic Malignancies
Conditions: Acute Leukemia; Chronic Leukemia; Chronic Myeloproliferative Disorders; Myelodysplastic and Myeloproliferative Disease108.RecruitingFludarabine, Cyclophosphamide, and Total-Body Irradiation in Treating Patients Who Are Undergoing an Umbilical Cord Blood Transplant for Hematologic Cancer
Conditions: Childhood Non-Hodgkin's Lymphoma; Chronic Myeloproliferative Disorders; Leukemia; Lymphoma; Multiple Myeloma and Other Plasma Cell Neoplasms; ...109.RecruitingCombination Chemotherapy, Tacrolimus, and Mycophenolate Mofetil in Treating Patients Who Are Undergoing a Donor Bone Marrow Transplant For Hematologic Cancer
Conditions: Childhood Hodgkin's Lymphoma; Childhood Non-Hodgkin's Lymphoma; Chronic Myeloproliferative Disorders; Leukemia; Lymphoma; ...110.RecruitingDonor Umbilical Cord Blood Transplant By Injection Into the Bone Marrow in Treating Patients With Hematologic Cancer
Conditions: Childhood Non-Hodgkin's Lymphoma; Chronic Myeloproliferative Disorders; Leukemia; Lymphoma111.RecruitingPeripheral Stem Cell Transplantation in Treating Patients With Hematologic Cancer or Aplastic Anemia
Conditions: Childhood Hodgkin's Lymphoma; Chronic Myeloproliferative Disorders; Leukemia; Lymphoma; Multiple Myeloma and Other Plasma Cell Neoplasms; ...112.RecruitingFludarabine and Total-Body Irradiation Followed By Cyclosporine and Mycophenolate Mofetil in Treating Patients Who Are Undergoing a Donor Peripheral Stem Cell Transplant for Hematologic Cancer
Conditions: Chronic Myeloproliferative Disorders; Leukemia; Lymphoma; Multiple Myeloma and Other Plasma Cell Neoplasms; ...113.RecruitingCaregiver Support in the Coping of Patients Who Are Undergoing a Donor Bone Marrow Transplant
Conditions: Chronic Myeloproliferative Disorders; Leukemia; Lymphoma; Multiple Myeloma and Other Plasma Cell Neoplasms; ...114.Not yet recruitingBusulfan and Fludarabine Before Donor Stem Cell Transplant in Treating Patients With Hematologic Cancer
Conditions: Anemia; Chronic Myeloproliferative Disorders; Leukemia; Lymphoma; Multiple Myeloma and Other Plasma Cell Neoplasms; ...115.RecruitingDonor Umbilical Cord Blood Stem Cell Transplant in Treating Patients With Hematologic Cancer
Conditions: Adult Acute Erythroid Leukemia; Childhood Non-Hodgkin's Lymphoma; Leukemia; Lymphoma116.RecruitingDonor Stem Cell Transplant Followed By Donor White Blood Cell Infusions in Treating Young Patients With Hematologic Cancer
Conditions: Acute Leukemia; Childhood Large Cell Lymphoma; Childhood Lymphoblastic Lymphoma; Childhood Small Noncleaved Cell Lymphoma; Chronic Leukemia; ...117.RecruitingTotal-Body Irradiation and Cyclophosphamide in Treating Patients Who Are Undergoing Donor Stem Cell Transplant for Hematologic Cancer and Other Diseases
Conditions: Hodgkin's Lymphoma; Acute Leukemia; Chronic Leukemia; Cutaneous T-Cell Lymphoma; Non-Hodgkin's Lymphoma118.RecruitingPentostatin in Treating Patients With Refractory Chronic Graft-Versus-Host Disease
Conditions: Breast Cancer; Endocrine Cancer; Female Reproductive Cancer; Graft Versus Host Disease; Hematopoietic and Lymphoid Cancer; Neuroblastoma119.RecruitingCombination Chemotherapy Followed By Umbilical Cord Blood Transplantation in Treating Patients With Hematologic Cancer or Severe Aplastic Anemia
Conditions: Adult Acute Erythroid Leukemia; Childhood Hodgkin's Lymphoma; Childhood Non-Hodgkin's Lymphoma; Hematopoietic and Lymphoid Cancer120.RecruitingClinical Evaluations and Laboratory Studies in Patients With Chronic Graft-Versus-Host Disease Who Have Undergone a Previous Donor Stem Cell Transplant
Conditions: Cancer; Graft Versus Host Disease121.RecruitingDonor Stem Cell Transplantation in Treating Patients With Hematologic Cancer
Conditions: Childhood Non-Hodgkin's Lymphoma; Leukemia; Lymphoma; Myelodysplastic and Myeloproliferative Diseases122.RecruitingImmunosuppresive Treatment Regimens With or Without Mycophenolate Mofetil in Treating Patients With Newly Diagnosed Chronic Graft-Versus-Host Disease
Conditions: Cancer; Graft Versus Host Disease123.RecruitingCyclophosphamide, Fludarabine, and Donor White Blood Cells in Treating Patients With Hematologic Cancer That Relapsed After a Previous Donor Stem Cell Transplant
Conditions: Childhood Non-Hodgkin's Lymphoma; Leukemia; Lymphoma; Multiple Myeloma and Other Plasma Cell Neoplasms; ...124.RecruitingUmbilical Cord Blood Transplantation in Treating Patients With High-Risk Hematologic Cancer
Conditions: Childhood Non-Hodgkin's Lymphoma; Graft Versus Host Disease; Leukemia; Lymphoma; Myelodysplastic and Myeloproliferative Diseases125.RecruitingDonor Umbilical Cord Blood Transplant in Treating Patients With Advanced Hematologic Cancer
Conditions: Adult Acute Monoblastic and Acute Monocytic Leukemia; Leukemia; Lymphoma; Multiple Myeloma and Other Plasma Cell Neoplasms126.RecruitingLow-Dose Fludarabine, Busulfan, and Anti-Thymocyte Globulin Followed By Donor Umbilical Cord Blood Transplant in Treating Patients With Advanced Hematologic Cancer
Conditions: Leukemia; Lymphoma; Multiple Myeloma and Other Plasma Cell Neoplasms127.RecruitingPalifermin in Reducing or Preventing Mucositis in Patients Who Are Receiving Radiation Therapy and Chemotherapy Followed by an Autologous Stem Cell Transplant for Hematologic Cancer
Conditions: Drug Toxicity; Leukemia; Lymphoma; Multiple Myeloma and Other Plasma Cell Neoplasms; Oral Complications of Cancer and Cancer Therapy; ...128.RecruitingFludarabine, Cyclophosphamide, and Total-Body Irradiation in Treating Patients Who Are Undergoing a Donor Bone Marrow Transplant for Hematologic Cancer
Conditions: Childhood Hodgkin's Lymphoma; Childhood Non-Hodgkin's Lymphoma; Chronic Myeloproliferative Disorders; Leukemia; Lymphoma; ...129.RecruitingT-Cell-Depleted Allogeneic Stem Cell Transplantation After Immunoablative Induction Chemotherapy and Reduced-Intensity Transplantation Conditioning in Treating Patients With Hematologic Malignancies
Conditions: Chronic Myeloproliferative Disorders; Leukemia; Lymphoma; Multiple Myeloma and Other Plasma Cell Neoplasms; ...130.RecruitingSirolimus in Preventing Graft-Versus-Host Disease in Patients With Hematologic Malignancies Who Are Undergoing Allogeneic Hematopoietic Stem Cell Transplantation
Conditions: Chronic Myeloproliferative Disorders; Graft Versus Host Disease; Leukemia; Lymphoma; Multiple Myeloma and Other Plasma Cell Neoplasms; ...131.RecruitingCombining Chemotherapy, Tacrolimus, Mycophenolate Mofetil, and Radiation Therapy With Donor Bone Marrow Transplantation in Treating Patients With Hematologic Cancer
Conditions: Childhood Hodgkin's Lymphoma; Childhood Non-Hodgkin's Lymphoma; Leukemia; Lymphoma; Multiple Myeloma and Other Plasma Cell Neoplasms; ...132.RecruitingPeripheral Stem Cell Transplantation in Treating Patients With Hematologic Cancer
Conditions: Langerhans Cell Histiocytosis; Childhood Hodgkin's Lymphoma; Childhood Non-Hodgkin's Lymphoma; Hematopoietic and Lymphoid Cancer133.RecruitingCyproheptadine and Megestrol in Preventing Weight Loss in Children With Cachexia Caused By Cancer or Cancer Treatment
Conditions: Cachexia; Childhood Hodgkin's Lymphoma; Childhood Brain Tumor; Childhood Non-Hodgkin's Lymphoma; Childhood Solid Tumor; ...134.RecruitingLaboratory-Treated Donor Bone Marrow in Treating Patients Who Are Undergoing a Donor Bone Marrow Transplant for Hematologic Cancer
Conditions: Childhood Hodgkin's Lymphoma; Childhood Non-Hodgkin's Lymphoma; Graft Versus Host Disease; Hematopoietic and Lymphoid Cancer135.RecruitingFludarabine, Cyclophosphamide, and Total-Body Irradiation Followed By an Umbilical Cord Blood Transplant, Cyclosporine, and Mycophenolate Mofetil in Treating Patients With Hematologic Cancer
Conditions: Childhood Hodgkin's Lymphoma; Childhood Non-Hodgkin's Lymphoma; Hematopoietic and Lymphoid Cancer136.RecruitingG-CSF-Treated Donor Bone Marrow Transplant in Treating Patients With Hematologic Disorders
Conditions: Childhood Hodgkin's Lymphoma; Childhood Non-Hodgkin's Lymphoma; Childhood Rhabdomyosarcoma; Graft Versus Host Disease; ...137.RecruitingDonor Peripheral Stem Cell Transplant in Treating Patients With Hematologic Cancer
Conditions: Childhood Hodgkin's Lymphoma; Childhood Non-Hodgkin's Lymphoma; Hematopoietic and Lymphoid Cancer138.RecruitingDonor Stem Cell Transplant or Donor White Blood Cell Infusions in Treating Patients With Hematologic Cancer
Conditions: Childhood Hodgkin's Lymphoma; Childhood Non-Hodgkin's Lymphoma; Hematopoietic and Lymphoid Cancer; Unusual Cancers of Childhood139.RecruitingDonor Umbilical Cord Blood Transplant in Treating Patients With Hematologic Cancer
Conditions: Diamond-Blackfan Anemia; Fanconi's Anemia; Childhood Hodgkin's Lymphoma; Childhood Non-Hodgkin's Lymphoma; Graft Versus Host Disease; ...140.RecruitingDonor Stem Cell Transplant in Treating Patients With Hematologic Cancer, Metastatic Kidney Cancer, or Aplastic Anemia
Conditions: Childhood Hodgkin's Lymphoma; Childhood Non-Hodgkin's Lymphoma; Hematopoietic and Lymphoid Cancer; Kidney and Urinary Cancer141.Not yet recruitingMusic Therapy or Book Discussion in Improving Quality of Life in Young Patients Undergoing Stem Cell Transplant
Conditions: Cancer; Fatigue; Pain; Psychosocial Effects and Treatment142.RecruitingMoxifloxacin Compared With Ciprofloxacin/Amoxicillin in Treating Fever and Neutropenia in Patients With Cancer
Conditions: Adult Solid Tumor; Fever, Sweats, and Hot Flashes; Hematopoietic and Lymphoid Cancer; Infection; Neutropenia143.RecruitingTacrolimus and Mycophenolate Mofetil in Preventing Graft-Versus-Host Disease in Patients Who Have Undergone Donor Stem Cell Transplantation for Hematologic Cancer
Conditions: Childhood Hodgkin's Lymphoma; Childhood Non-Hodgkin's Lymphoma; Graft Versus Host Disease; Hematopoietic and Lymphoid Cancer144.RecruitingCaspofungin Acetate in Treating Aspergillosis in Patients With Hematologic Cancer or in Patients Who Have Undergone a Stem Cell Transplant
Conditions: Cancer; Infection145.RecruitingCombination Chemotherapy and Bone Marrow Transplantation in Treating Patients With Aplastic Anemia or Hematologic Cancer
Conditions: Childhood Hodgkin's Lymphoma; Childhood Non-Hodgkin's Lymphoma; Hematopoietic and Lymphoid Cancer146.RecruitingAcupuncture in Treating Mucositis-Related Pain Caused by Chemotherapy in Patients Undergoing Stem Cell Transplantation
Conditions: Cancer; Oral Complications of Cancer and Cancer Therapy; Pain147.RecruitingLight-Emitting Diode Therapy in Preventing Mucositis in Children Receiving Chemotherapy With or Without Radiation Therapy Before Bone Marrow Transplantation
Conditions: Cancer; Oral Complications of Cancer and Cancer Therapy; Pain148.Not yet recruitingEtanercept in Treating Young Patients With Idiopathic Pneumonia Syndrome After Undergoing a Donor Stem Cell Transplant
Conditions: Cancer; Pulmonary Complications149.RecruitingRasburicase in Treating or Preventing High Levels of Uric Acid in the Blood and Tumor Lysis Syndrome in Patients With Relapsed or Refractory Lymphoma, Leukemia, or Solid Tumors
Conditions: Cancer; Hyperuricemia; Tumor Lysis Syndrome150.RecruitingImatinib Mesylate in Patients With Various Types of Malignancies Involving Activated Tyrosine Kinase Enzymes
Conditions: Hypereosinophilic Syndrome; Systemic Mastocytosis; Chronic Myelomonocytic Leukemia; Dermatofibrosarcoma

151.RecruitingCombination Chemotherapy and Radiation Therapy Followed By Cyclosporine and Mycophenolate Mofetil in Treating Patients Who Are Undergoing a Donor Stem Cell Transplant for Hematologic Cancer, Metastatic Breast Cancer, or Kidney Cancer
Conditions: Breast Cancer; Childhood Hodgkin's Lymphoma; Childhood Non-Hodgkin's Lymphoma; Hematopoietic and Lymphoid Cancer; Kidney and Urinary Cancer152.RecruitingAlemtuzumab, Total-Body Irradiation, and Fludarabine Followed By Donor Peripheral Stem Cell Transplantation in Treating Patients With Hematologic Cancer
Conditions: Childhood Hodgkin's Lymphoma; Childhood Non-Hodgkin's Lymphoma; Hematopoietic and Lymphoid Cancer153.RecruitingFludarabine, Cyclophosphamide, and Total-Body Irradiation Followed by Cyclosporine and Mycophenolate Mofetil in Treating Patients Who Are Undergoing a Donor Umbilical Cord Blood Transplant for Hematologic Cancers
Conditions: Childhood Hodgkin's Lymphoma; Childhood Non-Hodgkin's Lymphoma; Graft Versus Host Disease; Hematopoietic and Lymphoid Cancer154.RecruitingPentostatin and Donor White Blood Cells in Preventing Graft Rejection in Cancer Patients Who Have Undergone Donor Stem Cell Transplantation
Conditions: Cancer; Graft Versus Host Disease155.RecruitingAlemtuzumab, Tacrolimus, and Methylprednisolone in Treating Acute Graft-Versus-Host Disease in Patients Who Have Undergone Donor Stem Cell Transplant
Conditions: Breast Cancer; Endocrine Cancer; Female Reproductive Cancer; Graft Versus Host Disease; Hematopoietic and Lymphoid Cancer; Neuroblastoma156.RecruitingFludarabine and Total-Body Irradiation Followed By a Donor Stem Cell Transplant and Cyclosporine and Mycophenolate Mofetil in Treating HIV-Positive Patients With or Without Cancer
Conditions: Adult Solid Tumor; Childhood Solid Tumor; Hematopoietic and Lymphoid Cancer157.RecruitingAprepitant, Ondansetron, and Dexamethasone in Preventing Nausea and Vomiting in Patients Who Are Undergoing a Stem Cell Transplant
Conditions: Cancer; Nausea and Vomiting158.RecruitingCaregiver Support in the Quality of Life of Patients Who Are Undergoing Donor Bone Marrow Transplantation
Conditions: Cancer; Psychosocial Effects and Treatment; Quality of Life159.RecruitingAprepitant, Granisetron, and Dexamethasone in Preventing Nausea and Vomiting in Patients Receiving Cyclophosphamide Before a Stem Cell Transplant
Conditions: Breast Cancer; Endocrine Cancer; Female Reproductive Cancer; Hematopoietic and Lymphoid Cancer; Nausea and Vomiting; Neuroblastoma160.RecruitingZoledronate in Preventing Osteoporosis in Patients Undergoing Donor Stem Cell Transplant
Conditions: Breast Cancer; Endocrine Cancer; Female Reproductive Cancer; Hematopoietic and Lymphoid Cancer; Neuroblastoma; Osteoporosis161.Not yet recruitingMoxifloxacin in Preventing Bacterial Infections in Patients Who Have Undergone Donor Stem Cell Transplant
Conditions: Breast Cancer; Endocrine Cancer; Female Reproductive Cancer; Hematopoietic and Lymphoid Cancer; Infection; Neuroblastoma162.RecruitingAlemtuzumab, Fludarabine, and Total-Body Irradiation Followed by Cyclosporine and Mycophenolate Mofetil in Treating Patients Who Are Undergoing a Donor Stem Cell Transplant for Hematologic Cancer
Conditions: Childhood Hodgkin's Lymphoma; Childhood Non-Hodgkin's Lymphoma; Graft Versus Host Disease; Hematopoietic and Lymphoid Cancer163.RecruitingHigh-Dose Chemotherapy, Total-Body Irradiation, and Autologous Stem Cell Transplantation or Bone Marrow Transplantation in Treating Patients With Hematologic Cancer or Solid Tumors
Condition: Cancer164.RecruitingTotal-Body Irradiation With Or Without Fludarabine Followed By Allogeneic Hematopoietic Stem Cell Transplantation in Treating Patients With Hematologic Malignancies
Conditions: Childhood Hodgkin's Lymphoma; Childhood Non-Hodgkin's Lymphoma; Leukemia; Lymphoma; Multiple Myeloma and Other Plasma Cell Neoplasms165.RecruitingFluconazole Compared With Voriconazole in Preventing Invasive Fungal Infections in Patients Undergoing Allogeneic Hematopoietic Transplantation
Conditions: Childhood Non-Hodgkin's Lymphoma; Infection; Leukemia; Lymphoma; Myelodysplastic and Myeloproliferative Diseases166.RecruitingFluconazole Compared With Voriconazole in Preventing Invasive Fungal Infections in Patients Undergoing Allogeneic Hematopoietic Transplantation
Conditions: Childhood Non-Hodgkin's Lymphoma; Infection; Leukemia; Lymphoma; Myelodysplastic and Myeloproliferative Diseases167.RecruitingTacrolimus and Mycophenolate Mofetil With or Without Sirolimus in Preventing Acute Graft-Versus-Host Disease in Patients Who Are Undergoing Donor Stem Cell Transplant for Hematologic Cancer
Conditions: Childhood Hodgkin's Lymphoma; Childhood Non-Hodgkin's Lymphoma; Graft Versus Host Disease; Hematopoietic and Lymphoid Cancer168.RecruitingCombination Chemotherapy Plus Alemtuzumab Followed by Peripheral Stem Cell Transplantation in Treating Patients With Hematologic Cancer
Conditions: Childhood Hodgkin's Lymphoma; Childhood Non-Hodgkin's Lymphoma; Leukemia; Lymphoma; Multiple Myeloma and Other Plasma Cell Neoplasms; ...169.RecruitingUmbilical Cord Blood for Stem Cell Transplantation in Treating Young Patients With Malignant or Nonmalignant Diseases
Conditions: Fanconi's Anemia; Cancer170.RecruitingXK469R in Treating Patients With Refractory Hematologic Cancer
Conditions: Acute Leukemia; Adult Acute Erythroid Leukemia; Adult Acute Monoblastic and Acute Monocytic Leukemia; Chronic Leukemia171.RecruitingMonoclonal Antibody Therapy After Allogeneic Stem Cell Transplantation in Treating Patients With Persistent or Progressive Cancer
Conditions: Breast Cancer; Endocrine Cancer; Female Reproductive Cancer; Hematopoietic and Lymphoid Cancer; Neuroblastoma172.RecruitingEvaluating a New Transplant Regimen for High-Risk Leukemia Patients with Partially Matched Related Donors
Condition: Leukemia173.RecruitingVorinostat With or Without Isotretinoin in Treating Young Patients With Recurrent or Refractory Solid Tumors, Lymphoma, or Leukemia
Condition: Cancer174.RecruitingTopotecan in Treating Young Patients With Neoplastic Meningitis Due to Leukemia, Lymphoma, or Solid Tumors
Condition: Cancer175.RecruitingCyclophosphamide and/or Mycophenolate Mofetil With or Without Tacrolimus in Treating Patients Who Are Undergoing a Donor Bone Marrow or Peripheral Stem Cell Transplant for Hematologic Cancer
Conditions: Chronic Myeloproliferative Disorders; Graft Versus Host Disease; Leukemia; Lymphoma; Multiple Myeloma and Other Plasma Cell Neoplasms; ...176.RecruitingPeripheral Stem Cell Transplantation Plus Monoclonal Antibody Therapy in Treating Patients With High-Risk Hematologic Cancer, Refractory Breast or Kidney Cancer, or Melanoma
Conditions: Breast Cancer; Hematopoietic and Lymphoid Cancer; Kidney and Urinary Cancer; Skin Tumor177.RecruitingDonor Lymphocyte Infusion in Treating Patients With Persistent, Relapsed, or Progressing Cancer After Allogeneic Transplantation
Conditions: Cancer; Graft Versus Host Disease178.RecruitingA Notch Signalling Pathway Inhibitor for Patients With T-Cell Acute Lymphoblastic Leukemia/Lymphoma (ALL)
Conditions: Leukemia, Lymphoblastic, Acute, T-Cell; Myelogenous Leukemia; Chronic Lymphocytic Leukemia; Myelodysplastic Syndromes179.RecruitingStem Cell Transplantation and T-Cell Add-Back to Treat Bone Marrow Malignancies
Conditions: Leukemia; Bone Marrow Transplantation180.RecruitingFenretinide in Treating Patients With Refractory or Relapsed Hematologic Cancer
Conditions: Hodgkin's Lymphoma; Acute Leukemia; Chronic Leukemia; Chronic Myeloproliferative Disorders; Non-Hodgkin's Lymphoma; Plasma Cell Neoplasm181.RecruitingDonor Stem Cell Transplant in Treating Older or Frail Patients With Hematologic Cancer
Conditions: Chronic Myeloproliferative Disorders; Leukemia; Lymphoma; Multiple Myeloma and Other Plasma Cell Neoplasms182.RecruitingSpecialized Blood Cell Transplants for Cancers of the Blood and Bone Marrow
Conditions: Hematologic Disease; Lymphoma; Multiple Myeloma; Myelodysplastic Syndrome; Myeloproliferative Disorder183.RecruitingMS-275 and Azacitidine in Treating Patients With Myelodysplastic Syndromes, Chronic Myelomonocytic Leukemia, or Acute Myeloid Leukemia
Conditions: Adult Acute Myeloid Leukemia; Chronic Myelomonocytic Leukemia; Myelodysplastic Syndromes; Secondary Acute Myeloid Leukemia184.Not yet recruitingAzacitidine With or Without MS-275 in Treating Patients With Myelodysplastic Syndromes, Chronic Myelomonocytic Leukemia, or Acute Myeloid Leukemia
Conditions: De Novo Myelodysplastic Syndromes; Untreated Adult Acute Myeloid Leukemia; Chronic Myelomonocytic Leukemia; ...185.RecruitingIdarubicin, Cytarabine, and Tipifarnib in Treating Patients With Newly Diagnosed Myelodysplastic Syndromes or Acute Myeloid Leukemia
Conditions: Adult Acute Erythroid Leukemia; Adult Acute Monoblastic and Acute Monocytic Leukemia; Adult Acute Myeloid Leukemia; ...186.RecruitingIdarubicin, Cytarabine, and Gemtuzumab Ozogamicin in Treating Patients With Previously Untreated High-Risk Myelodysplastic Syndrome or Acute Myeloid Leukemia Secondary to Myelodysplastic Syndrome
Conditions: Adult Acute Myeloid Leukemia; Chronic Myelomonocytic Leukemia; Myelodysplastic Syndromes187.RecruitingTipifarnib in Treating Patients With Acute Myeloid Leukemia or Myelodysplastic Syndrome in Complete Remission
Conditions: Adult Acute Monoblastic and Acute Monocytic Leukemia; Adult Acute Myeloid Leukemia; Chronic Myelomonocytic Leukemia; Myelodysplastic Syndromes188.RecruitingDasatinib as Therapy for Myeloproliferative Disorders (MPDs)
Conditions: Acute Myeloid Leukemia; Myelodysplastic Syndromes; Agnogenic Myeloid Metaplasia; Myelofibrosis; Hypereosinophilic Syndrome; Polycythemia Vera; ...189.Recruiting17-N-Allylamino-17-Demethoxygeldanamycin (17-AAG) in Treating Young Patients With Recurrent or Refractory Leukemia or Solid Tumors
Conditions: Ewing's Family of Tumors; Childhood Rhabdomyosarcoma; Childhood Soft Tissue Sarcoma; Hematopoietic and Lymphoid Cancer; Neuroblastoma; Osteosarcoma190.RecruitingQuality of Life of Adult Cancer Survivors Who Have Undergone a Previous Bone Marrow or Peripheral Stem Cell Transplant for a Childhood Hematologic Cancer
Conditions: Childhood Hodgkin's Lymphoma; Childhood Non-Hodgkin's Lymphoma; Leukemia; Quality of Life191.RecruitingArsenic Trioxide and Gemtuzumab Ozogamicin in Treating Patients With Advanced Myelodysplastic Syndromes
Conditions: Chronic Myelomonocytic Leukemia; Myelodysplastic Syndromes; Secondary Acute Myeloid Leukemia192.RecruitingAnti-Thymocyte Globulin and Etanercept in Treating Patients With Myelodysplastic Syndromes
Conditions: De Novo Myelodysplastic Syndromes; Previously Treated Myelodysplastic Syndromes; Secondary Myelodysplastic Syndromes; ...193.RecruitingTraumeelĀ® S in Preventing and Treating Mucositis in Young Patients Undergoing Stem Cell Transplantation
Conditions: Cancer; Oral Complications of Cancer and Cancer Therapy194.RecruitingStem Cell Transplant for Hematological Malignancy
Conditions: Leukemia, Myeloid, Chronic; AML; Leukemia, Lymphocytic, Acute; MDS; Leukemia, Lymphocytic, Chronic; JMML; Hodgkin's Disease; Non-Hodgkin's Lymphoma; ...195.RecruitingImmunoablative Mini Transplant (Hematopoietic Peripheral Blood Stem Cell Transplant [HPBSC])
Conditions: Tumors; Malignant Melanoma; Hematological Malignancies; Myelogenous Leukemia, Chronic; Leukemia, Lymphoblastic, Acute196.RecruitingA Randomized Study Comparing Imatinib With Chemotherapy as Induction in Elderly Patients With Philadelphia Positive ALL
Conditions: Philadelphia Positive Acute Lymphoblastic Leukemia; Lymphoid Blastic Phase of Chronic Myeloid Leukemia197.RecruitingPost Transplant Donor Lymphocyte Infusion
Conditions: Leukemia, Myeloid, Chronic; Lymphomas; Multiple Myeloma; Myelodysplastic Syndrome; Leukemia, Lymphocytic, Acute; Leukemia, Lymphocytic, Chronic; AML198.RecruitingSafety Assessment of Two Schedules of Intravenous Infusions of SNS-595 for the Treatment of Hematologic Malignancies
Conditions: Leukemia, Lymphocytic, Acute; Leukemia, Nonlymphocytic, Acute; Leukemia, Myeloid, Chronic; Myelodysplastic Syndromes199.RecruitingStudy of Lonafarnib Versus Placebo in Subjects With Either Myelodysplastic Syndrome (MDS) or Chronic Myelomonocytic Leukemia (CMML) (Study P02978)
Conditions: Myelodysplastic Syndrome; Chronic Myelomonocytic Leukemia200.RecruitingDLI for Relapsed (Post Transplant) Leukemia
Conditions: Leukemia, Myeloid, Chronic; AML; MDS; Leukemia, Lymphocytic, Acute

201.RecruitingDouble Cord Blood Transplant Study
Conditions: Leukemia, Lymphocytic, Acute; Leukemia, Myelocytic, Acute; Leukemia, Myeloid, Chronic; Lymphoma, Non-Hodgkin202.RecruitingVatalanib in Treating Patients With Primary or Secondary Myelodysplastic Syndromes
Conditions: Chronic Myelomonocytic Leukemia; Myelodysplastic and Myeloproliferative Disease; Myelodysplastic Syndromes203.RecruitingAzacitidine and Arsenic Trioxide in Treating Patients With Myelodysplastic Syndromes
Conditions: Chronic Myelomonocytic Leukemia; Myelodysplastic Syndromes204.RecruitingStudy of Three Different Schedules of Low-Dose Decitabine in Myelodysplastic Syndrome (MDS)
Conditions: Myelodysplastic Syndrome; Chronic Myelomonocytic Leukemia205.RecruitingIdarubicin and Cytarabine With or Without Bevacizumab in Treating Patients With Newly Diagnosed Acute Myeloid Leukemia
Conditions: Adult Acute Erythroid Leukemia; Adult Acute Monoblastic and Acute Monocytic Leukemia; Adult Acute Myeloid Leukemia; ...206.Not yet recruitingT-Cell and B-Cell Depletion in Allogeneic Peripheral Blood Stem Cell Transplantation
Conditions: Leukemia, Myeloid; Leukemia, Lymphocytic; Myelodysplastic Syndrome; Leukemia, Myeloid, Chronic; Lymphoma207.RecruitingSibling and Unrelated Donor Hematopoietic Cell Transplant in Hematologic Malignancies
Conditions: Acute Disease; Leukemia, Myeloid, Chronic; Myelodysplastic Syndromes; Myeloproliferative Disorders208.RecruitingAutologous Peripheral Stem Cell or Bone Marrow Transplant Using Laboratory-Treated Cells in Treating Patients With Acute Leukemia
Conditions: Acute Lymphocytic Leukemia; Acute Myeloid Leukemia; Adult Acute Erythroid Leukemia; Adult Acute Monoblastic and Acute Monocytic Leukemia; ...209.RecruitingBusulfan, Cyclophosphamide, and Melphalan in Treating Young Patients Who Are Undergoing a Donor Stem Cell Transplant For Juvenile Myelomonocytic Leukemia
Condition: Juvenile Myelomonocytic Leukemia210.RecruitingCombination Chemotherapy Followed By Donor Bone Marrow or Umbilical Cord Blood Transplantation in Treating Children With Newly Diagnosed Juvenile Myelomonocytic Leukemia
Condition: Juvenile Myelomonocytic Leukemia211.RecruitingStem Cell Transplant for Juvenile Myelomonocytic Leukemia (JMML)
Condition: Juvenile Myelomonocytic Leukemia212.RecruitingLower-Dose Chemotherapy and Stem Cell Transplantation to Treat Childhood Leukemias and Lymphomas
Conditions: Hodgkin Lymphoma; Lymphocytic Leukemia; Mixed Cell Leukemia; Myelodysplastic Syndrome; Non Hodgkin's Lymphoma213.RecruitingImatinib Mesylate to Treat Myeloproliferative Hypereosinophilic Syndrome
Condition: Hypereosinophilic Syndrome214.RecruitingDecitabine and Valproic Acid in Treating Patients With Refractory or Relapsed Acute Myeloid Leukemia or Previously Treated Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma
Conditions: Adult Acute Myeloid Leukemia; Refractory Chronic Lymphocytic Leukemia; Small Lymphocytic Lymphoma215.RecruitingMegadose CD34 Selected Progenitor Cells for Transplantation in Patients With Advanced Hematological Malignant Diseases
Conditions: Acute Myelogenous Leukemia; Acute Lymphocytic Leukemia; Myelodysplastic Syndrome; Chronic Lymphocytic Leukemia; Non Hodgkin's Lymphoma216.RecruitingStudy of Immune Response Modifier in the Treatment of Hematologic Malignancies
Conditions: Acute Lymphoblastic Leukemia; Acute Myeloid Leukemia; Non-Hodgkin's Lymphoma; Hodgkin's Lymphoma; Multiple Myeloma; Chronic Lymphocytic Leukemia217.RecruitingAnalysis of Genetic Factors Related to Predisposition and Prognosis of Hematological Malignancies in Israel
Conditions: Acute Myeloid Leukemia; Chronic Lymphocytic Leukemia218.Recruiting17-N-Allylamino-17-Demethoxygeldanamycin and Bortezomib in Treating Patients With Relapsed or Refractory Hematologic Cancer
Conditions: Adult Acute Erythroid Leukemia; Adult Acute Monoblastic and Acute Monocytic Leukemia; Leukemia; Lymphoma; Small Intestine Cancer219.RecruitingPhase II Trial of Prophylactic Rituximab Therapy for Prevention of CGVHD
Conditions: Mast Cell Leukemia; Chronic Lymphocytic Leukemia220.RecruitingA Safety Study of SGN-33 in Patient With Acute Myeloid Leukemia and Myelodysplastic Syndrome
Conditions: Acute Myeloid Leukemia (AML); Myelodyplastic Syndrome (MDS); CD33+ Myeloproliferative Syndromes; CMMoL221.RecruitingCD8+ T-Cell Depleted DLI After Nonmyeloablative Stem Cell Transplantation for AML and High Risk MDS
Conditions: Acute Myeloid Leukemia (AML); High Risk Myelodysplastic Syndrome (MDS)222.RecruitingMusic Therapy to Ease Pain and Emotional Distress in Patients With Hematologic Cancer Who Are Undergoing High-Dose Therapy and Stem Cell Transplantation
Conditions: Adult Hodgkin's Lymphoma; Adult Non-Hodgkin's Lymphoma; Anxiety Disorder; Childhood Acute Myeloid Leukemia and Other Myeloid Malignancies; ...223.Recruiting825A in Treating Patients With Hematologic Cancer That is Not Responding to Standard Treatment
Conditions: Childhood Hodgkin's Lymphoma; Childhood Lymphomatoid Granulomatosis; Childhood Non-Hodgkin's Lymphoma; Leukemia; Lymphoma; ...224.RecruitingWT1 for the Detection of Minimal Residual Disease
Conditions: Leukemia; Cancer225.RecruitingChemotherapy for Patients With Advanced Solid Tumors or Non-Hodgkin's Lymphoma
Conditions: Solid Malignancies; Non-Hodgkin's Lymphoma226.RecruitingRevlimid and Azacitidine for Treating Advanced Myelodysplastic Syndrome (MDS)
Conditions: Anemia, Refractory; Myelodysplastic Syndromes


This page is powered by Blogger. Isn't yours?